| ปี พ.ศ. 2556 |
| 1 |
Pharmacological assessment of efavirenz weight-band dosing recommendations in HIV-infected thai children |
| ปี พ.ศ. 2555 |
| 2 |
Recovery from lipodystrophy in HIV-infected children after substitution of stavudine with zidovudine in a non-nucleoside reverse transcriptase inhibitor-based antiretroviral therapy |
| 3 |
Immune reconstitution inflammatory syndrome from Penicillium marneffei in an HIV-infected child: A case report and review of literature |
| 4 |
High virologic response rate after second-line boosted protease inhibitor-based antiretroviral therapy regimens in children from a resource limited setting |
| 5 |
Causes of first hospitalization among 1121 HIV-infected children: Comparison of the pre-Pneumocystis jiroveci pneumonia prophylaxis, pre-antiretroviral therapy and antiretroviral therapy periods |
| 6 |
Effectiveness and safety of protease inhibitor-based regimens in HIV-infected Thai children failing first-line treatment |
| 7 |
HIV and hepatitis B coinfection among perinatally HIV-infected thai adolescents |
| ปี พ.ศ. 2554 |
| 8 |
Cohort profile: The TREAT Asia pediatric HIV observational database |
| 9 |
Successful treatment of a child with vascular pythiosis |
| 10 |
Economic evaluation of monitoring virologic responses to antiretroviral therapy in HIV-infected children in resource-limited settings |
| 11 |
Prevalence of protective level of hepatitis B antibody 3 years after revaccination in HIV-infected children on antiretroviral therapy |
| 12 |
Pharmacokinetics and safety of a new paediatric fixed-dose combination of zidovudine/lamivudine/nevirapine in HIV-infected children |
| 13 |
Immunogenicity and safety of monovalent influenza A (H1N1) 2009 in HIV-infected Thai children |
| ปี พ.ศ. 2553 |
| 14 |
Persistence of measles, mumps, and rubella protective antibodies 3 years after revaccination in HIV-infected children receiving antiretroviral therapy |
| 15 |
Poor cognitive functioning of school-aged children in thailand with perinatally acquired HIV infection taking antiretroviral therapy |
| 16 |
Measles outbreak in an orphanage: HIV-Infected children on antiretroviral therapy are still at risk |
| 17 |
HIV-1 drug resistance mutations in children after failure of first-line nonnucleoside reverse transcriptase inhibitor-based antiretroviral therapy |
| 18 |
A chewable pediatric fixed-dose combination tablet of stavudine, lamivudine, and nevirapine: Pharmacokinetics and safety compared with the individual liquid formulations in human immunodeficiency virus-infected children in Thailand |
| 19 |
Fulminant enterovirus 71 infection: Case report |
| 20 |
Reply |
| 21 |
Antiretroviral therapy outcomes of HIV-infected children in the TREAT Asia pediatric HIV observational database |
| 22 |
Corrigendum to "Antibody response to hepatitis B virus re-vaccination in HIV-infected children with immune recovery on highly active antiretroviral therapy" [Vaccine 2007;25:5324-9] |
| 23 |
A 3-year follow-up of antibody response in HIV-infected children with immune recovery vaccinated with inactivated Japanese encephalitis vaccine |
| ปี พ.ศ. 2552 |
| 24 |
Efficacy of non-nucleoside reverse transcriptase inhibitor-based highly active antiretroviral therapy in thai hiv-infected children aged two years or less |
| 25 |
Plasma efavirenz concentrations and the association with CYP2B6-516G>T polymorphism in HIV-infected Thai Children |
| 26 |
Pattern and predictors of immunologic recovery in human immunodeficiency virus-infected children receiving non-nucleoside reverse transcriptase inhibitor-based highly active antiretroviral therapy |
| 27 |
Reversal of growth failure in HIV-infected Thai children treated with non-nucleoside reverse transcriptase inhibitor-based antiretroviral therapy |
| 28 |
Predictors of virologic failure and genotypic resistance mutation patterns in thai children receiving non-nucleoside reverse transcriptase inhibitor-based antiretroviral Therapy |
| 29 |
Low prevalence of insulin resistance among HIV-infected children receiving nonnucleoside reverse transcriptase inhibitor-based highly active antiretroviral therapy in Thailand |
| ปี พ.ศ. 2551 |
| 30 |
Haematological changes after switching from stavudine to zidovudine in HIV-infected children receiving highly active antiretroviral therapy |
| 31 |
Dilated cardiomyopathy in three HIV-infected children after initiation of antiretroviral therapy |
| 32 |
Acute fulminant myocarditis in scrub typhus |
| 33 |
Quality of life among HIV-infected children in Thailand |
| ปี พ.ศ. 2550 |
| 34 |
Response to measles, mumps, and rubella revaccination in HIV-infected children with immune recovery after highly active antiretroviral therapy |
| 35 |
Hospitalization and mortality among HIV-infected children after receiving highly active antiretroviral therapy |
| 36 |
Sustained immunologic and virologic efficacy after four years of highly active antiretroviral therapy in human immunodeficiency virus infected children in Thailand |
| 37 |
Lipodystrophy and metabolic changes in HIV-infected children on non-nucleoside reverse transcriptase inhibitor-based antiretroviral therapy |
| 38 |
Japanese encephalitis vaccination in HIV-infected children with immune recovery after highly active antiretroviral therapy |
| ปี พ.ศ. 2549 |
| 39 |
Immune reconstitution syndrome after highly active antiretroviral therapy in human immunodeficiency virus-infected Thai children |
| 40 |
Immune reconstitution syndrome from nontuberculous mycobacterial infection after initiation of antiretroviral therapy in children with HIV infection |
| 41 |
Disclosure of HIV/AIDS diagnosis to HIV-infected children in Thailand |
| 42 |
Prevalence of protective antibody against hepatitis B virus in HIV-infected children with immune recovery after highly active antiretroviral therapy |
| 43 |
Prevalence of protective antibody against measles in HIV-infected children with immune recovery after highly active antiretroviral therapy |
| ปี พ.ศ. 2548 |
| 44 |
Efficacy of highly active antiretroviral therapy in HIV-infected children participating in Thailand's National Access to Antiretroviral Program |
| 45 |
Cryptococcosis in HIV-infected children |
| 46 |
Growth, developmental, and behavioral outcomes of HIV-affected preschool children in Thailand |
| 47 |
Immune reconstitution syndrome due to bacillus Calmette-Gu?rin after initiation of antiretroviral therapy in children with HIV infection |
| 48 |
Cardiac manifestations in HIV-infected Thai children |
| 49 |
Impact of gastrointestinal endoscopy on HIV-infected children |
| ปี พ.ศ. 2547 |
| 50 |
Epidemiologic, clinical and laboratory features of scrub typhus in thirty Thai children |
| ปี พ.ศ. 2546 |
| 51 |
An in-house HIV DNA PCR assay for early diagnosis of HIV infection in children in Thailand |
| 52 |
Cytomegalovirus-associated manifestations involving the digestive tract in children with human immunodeficiency virus infection |
| ปี พ.ศ. 2542 |
| 53 |
Penicillium Marneffei Mesenteric Lymphadenitis in Human Immunodeficiency Virus -infected Children |
| ปี พ.ศ. 2540 |
| 54 |
Primary sequence of the envelope glycoprotein of a dengue type 2 virus isolated from patient with dengue hemorrhagic fever and encephalopathy |
| 55 |
Immunohistochemical characterization of a new monoclonal antibody reactive with dengue virus-infected cells in frozen tissue using immunoperoxidase technique |
| ปี พ.ศ. 2539 |
| 56 |
Disseminated Penicillium marneffei infection in human immunodeficiency virus-infected children |
| ปี พ.ศ. 2538 |
| 57 |
First cases of spotted fever group rickettsiosis in Thailand |
| 58 |
Histopathologic spectrum of AIDS associated lesions in Maharaj Nakorn Chiang Mai hospital |
| ปี พ.ศ. 2537 |
| 59 |
Penicillium marneffei infection in children infected with human immunodeficiency virus |
| 60 |
Outbreak of oral-oropharyngeal anthrax: An unusual manifestation of human infection with Bacillus anthracis |
| ปี พ.ศ. 2536 |
| 61 |
Corynebacterium diphtheriae endocarditis |
| ปี พ.ศ. ไม่ระบุ |
| 62 |
Antibody response to hepatitis B re-vaccination in HIV-infected children with immune recovery on highly active antiretroviral therapy |
| 63 |
Antibody responses to hepatitis A virus vaccination in Thai HIV-infected children with immune recovery after antiretroviral therapy |
| 64 |
Antibody responses to hepatitis A virus vaccination in Thai HIV-infected children with immune recovery after antiretroviral therapy |
| 65 |
Antibody response to hepatitis B re-vaccination in HIV-infected children with immune recovery on highly active antiretroviral therapy |
| 66 |
An in-house HIV DNA PCR assay for early diagnosis of HIV infection in children in Thailand |
